Showing 4091-4100 of 20455 results for "".
- Harnessing Specialized LLMs for Improved Postoperative Risk Predictionhttps://reachmd.com/news/harnessing-specialized-llms-for-improved-postoperative-risk-prediction/2471418/Revolutionizing Surgical Outcomes with Advanced Predictive Analytics This article examines how specialized large language models (LLMs) are changing the landscape of postoperative risk prediction. Evidence suggests that these advanced models outperform traditional
- TSC Reduces Tretinoin-Induced Skin Irritation: Pilot Studyhttps://reachmd.com/news/tsc-reduces-tretinoin-induced-skin-irritation-pilot-study/2471409/A recent pilot study has shown that tetramethylhexadecenyl succinoyl cysteine (TSC) significantly reduces erythema and dryness caused by tretinoin application. These findings may offer a novel approach to minimizing the common adverse effects of tretinoin, potential
- Genomic Insights into Breast Cancer Subtypes: A Path to Targeted Therapieshttps://reachmd.com/news/genomic-insights-into-breast-cancer-subtypes-a-path-to-targeted-therapies/2471405/Recent research unveils the complex genomic rearrangements driving ER+ and HER2+ breast tumors, offering new pathways for targeted therapies and personalized treatment strategies. Understanding Genomic Rearrangements in Breast Cancer Ne
- The Ineffectiveness of Brain Stimulation in Post-Stroke Motor Recoveryhttps://reachmd.com/news/the-ineffectiveness-of-brain-stimulation-in-post-stroke-motor-recovery/2471367/Recent studies reveal that brain stimulation techniques, once hoped to enhance motor recovery in stroke survivors, show no significant benefit when combined with movement therapy. Understanding the Study Context The exploration into bra
- Diversity in Clinical Trials: Innovative Recruitment Strategies for Psoriasis Researchhttps://reachmd.com/news/diversity-in-clinical-trials-innovative-recruitment-strategies-for-psoriasis-research/2473903/Diversity in clinical trials is critical, especially for psoriasis studies focusing on patients of varied skin tones. Effective
- Innovative Models for Personalized Brain Tumor Therapy: The Future of Oncologyhttps://reachmd.com/news/innovative-models-for-personalized-brain-tumor-therapy-the-future-of-oncology/2471385/Recent advancements in brain tumor research are paving the way for personalized cancer treatments that mimic the original tumors more closely than ever before, offering new hope for patients with challenging conditions like glioblastoma. Revolu
- Childhood Trauma and Neighborhood Conditions Impact Injury Recovery in Black Menhttps://reachmd.com/news/childhood-trauma-and-neighborhood-conditions-impact-injury-recovery-in-black-men/2471381/A recent study from the University of Pennsylvania School of Nursing, published in the Journal of Urban Health, examines how early-life trauma and neighborhood conditions affect the mental health recovery of Black men in Phi
- Subcortical Shape Alterations Reveal New Insights into Parkinson’s Disease Progressionhttps://reachmd.com/news/subcortical-shape-alterations-reveal-new-insights-into-parkinsons-disease-progression/2471375/Recent studies highlight the role of subcortical shape changes as potential markers for clinical staging in Parkinson's disease, offering novel avenues for diagnostics and treatment. Understanding Subcortical Changes Recent studies have
- Investigating Potential Ocular Risks of Weight-Loss Drugshttps://reachmd.com/news/investigating-potential-ocular-risks-of-weight-loss-drugs/2471333/Research conducted at the University of Utah's John A. Moran Eye Center explored potential vision complications in patients using semaglutide and tirzepatide, commonly prescribed weight-loss drugs. The review of nine cases suggests that rapid alterations in blood sugar level
- Innovative ALS Platform Trial: A New Approach to Drug Testinghttps://reachmd.com/news/innovative-als-platform-trial-a-new-approach-to-drug-testing/2471274/The HEALEY ALS Platform Trial marks a significant shift in how amyotrophic lateral sclerosis treatments are tested, promising faster and more cost-effective drug development. The HEALEY ALS Platform Trial represents a groundbreaking approach to